Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H17Na2O6P |
InChIKeyAFQVNGLMVRAHAT-GSBNXNDCSA-N |
CAS Registry441351-39-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 06 Jun 2002 |